ACUT 最新10-Q变化
将 ACUT 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-14 与上一份 10-Q · 2026-05-15
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +7 | −5 | ~8 | 46 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~3 | 5 |
| 风险因素 | 公司称无重大变化(指向 10-K) | — | — | — | — |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):法律诉讼、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-14
Other Income for the three and six months ended June 30, 2026, increased to $98,400, compared to $0 for the three and six months ended June 30, 2025, due to one-off credits against supplier invoices that were deemed no longer due and payable.
Research and development expenses for the three months ended June 30, 2026, decreased to $43,712 compared to $60,204, for the three months ended June 30, 2025, primarily due to timing of spend relating to technology transfer.
Research and development expenses for the six months ended June 30, 2026, increased to $163,237 compared to $88,550, for the six months ended June 30, 2025, primarily due to duplicate invoices received from a supplier last quarter, which are offset with credit notes received, reflected in other inco…
General and administrative expenses for three and six months ended June 30, 2026, decreased to $307,261 and $673,619, respectively, compared to $341,199 and $753,261, respectively, for the three and six months ended June 30, 2025 primarily due to no payroll related bonus costs incurred in 2026.
Since our inception, we have not generated any revenue and have incurred significant operating losses. Our potential products are at various phases of development. We do not expect to generate significant revenue from product sales for several years, if at all. Pursuant to the demerger, Tiziana tran…
相对上期删除的文字 · 来源:10-Q · 2026-05-15
Research and development expenses for the three months ended March 31, 2026, increased to $119,525, compared to $28,346 for the three months ended March 31, 2025 primarily due to an increase in MSC related laboratory work and consulting.
General and administrative expenses for three months ended March 31, 2026, decreased to $366,358, compared to $412,062 for the three months ended March 31, 2025 primarily due to no payroll related bonus costs incurred in 2026.
Since our inception, we have not generated any revenue and have incurred significant operating losses. Our potential products are at various phases of development. We do not expect to generate significant revenue from product sales for several years, if at all. Pursuant to the demerger, Tiziana tran…
Cash flows (used in) provided by financing activities 372,454 321,517
Net (decrease) increase in cash and cash equivalents (1,722) 31,335
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议